mirage

VS411 Reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics

Mak IR/Manakin Repository

Files in this item

This item appears in the following Collection(s)